Skip to main navigation Skip to search Skip to main content

Protocol Development and Study Design of Duac 3/5% Antimicrobial Resistance Study.

Activity: Consultancy

Description

GlaxoSmithKline Global Stiefel Medical Team
Period2016
Work forGlaxoSmithKline Global Stiefel Medical Team, United Kingdom
Degree of RecognitionInternational